156 related articles for article (PubMed ID: 27836206)
21. Genetic polymorphisms in
Si W; Kang S; Sun H; Chen J; Cao S; Li Y
Int J Gynecol Cancer; 2019 Sep; 29(7):1148-1155. PubMed ID: 31273068
[TBL] [Abstract][Full Text] [Related]
22. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
[TBL] [Abstract][Full Text] [Related]
23. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
Zhang HB; Zeng Y; Li TL; Wang G
Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
[TBL] [Abstract][Full Text] [Related]
24. Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with primary or secondary cytoreductive surgery in the treatment of advanced epithelial ovarian cancer.
Manzanedo I; Pereira F; Pérez-Viejo E; Serrano Á; Hernández-García M; Martínez-Torres B; Rihuete-Caro C; Calzas J; Cueto M
Minerva Ginecol; 2017 Apr; 69(2):119-127. PubMed ID: 27415829
[TBL] [Abstract][Full Text] [Related]
25. STAT3 polymorphisms may predict an unfavorable response to first-line platinum-based therapy for women with advanced serous epithelial ovarian cancer.
Permuth-Wey J; Fulp WJ; Reid BM; Chen Z; Georgeades C; Cheng JQ; Magliocco A; Chen DT; Lancaster JM
Int J Cancer; 2016 Feb; 138(3):612-9. PubMed ID: 26264211
[TBL] [Abstract][Full Text] [Related]
26. Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.
Lurie G; Wilkens LR; Thompson PJ; McDuffie KE; Carney ME; Terada KY; Goodman MT
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2566-71. PubMed ID: 18086759
[TBL] [Abstract][Full Text] [Related]
27. Genetic Association of Interleukin-31 Gene Polymorphisms with Epithelial Ovarian Cancer in Chinese Population.
Liu C; Wang Y; Song H; Li Q; Zhang Y; Chen P; Song Y; Su M; Huang Q; Wang M; Zhou B; Zhang L
Dis Markers; 2018; 2018():3503858. PubMed ID: 29484036
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
[TBL] [Abstract][Full Text] [Related]
29. Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer.
Paek J; Lee M; Nam EJ; Kim SW; Kim YT
Arch Gynecol Obstet; 2016 Mar; 293(3):645-50. PubMed ID: 26305032
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk.
Auranen A; Song H; Waterfall C; Dicioccio RA; Kuschel B; Kjaer SK; Hogdall E; Hogdall C; Stratton J; Whittemore AS; Easton DF; Ponder BA; Novik KL; Dunning AM; Gayther S; Pharoah PD
Int J Cancer; 2005 Nov; 117(4):611-8. PubMed ID: 15924337
[TBL] [Abstract][Full Text] [Related]
31. A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Richards EJ; Permuth-Wey J; Li Y; Chen YA; Coppola D; Reid BM; Lin HY; Teer JK; Berchuck A; Birrer MJ; Lawrenson K; Monteiro AN; Schildkraut JM; Goode EL; Gayther SA; Sellers TA; Cheng JQ
Oncotarget; 2015 Oct; 6(33):34745-57. PubMed ID: 26430965
[TBL] [Abstract][Full Text] [Related]
32. Does neoadjuvant chemotherapy plus cytoreductive surgery improve survival rates in patients with advanced epithelial ovarian cancer compared with cytoreductive surgery alone?
Solmaz U; Mat E; Dereli ML; Turan V; Peker N; Tosun G; Dogan A; Adiyeke M; Ozdemir A; Gungorduk K; Sanci M; Yildirim Y
J BUON; 2015; 20(3):847-54. PubMed ID: 26214639
[TBL] [Abstract][Full Text] [Related]
33. [Re-evaluation of interval debulking surgery in advanced epithelial ovarian cancer].
Ma Y; Li Y; Cui H; Liang XD; Tang ZJ; Li XP; Zhao Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):355-60. PubMed ID: 22883524
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of systematic lymph node dissection in advanced epithelial ovarian cancer during interval debulking surgery performed after neoadjuvant chemotherapy.
Eoh KJ; Yoon JW; Lee I; Lee JY; Kim S; Kim SW; Kim YT; Nam EJ
J Surg Oncol; 2017 Sep; 116(3):329-336. PubMed ID: 28542980
[TBL] [Abstract][Full Text] [Related]
35. Association between polymorphisms in xenobiotic detoxification-related genes with prognosis of epithelial ovarian cancer.
Carron J; Brito AB; Torelli AC; Oliveira C; Derchain SF; Lima CS; Lourenço GJ
Med Oncol; 2016 Oct; 33(10):112. PubMed ID: 27586145
[TBL] [Abstract][Full Text] [Related]
36. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
37. Relationship between PIWIL1 gene polymorphisms and epithelial ovarian cancer susceptibility among southern Chinese woman: a three-center case-control study.
Liu S; Yan Y; Cui Z; Feng H; Zhong F; Liu Z; Li Y; Ou X; Li W
BMC Cancer; 2023 Nov; 23(1):1149. PubMed ID: 38012622
[TBL] [Abstract][Full Text] [Related]
38. Associations of ICOS and PD.1 Gene Variants with Colon Cancer Risk in The Iranian Population.
Shamsdin SA; Karimi MH; Hosseini SV; Geramizadeh B; Fattahi MR; Mehrabani D; Moravej A
Asian Pac J Cancer Prev; 2018 Mar; 19(3):693-698. PubMed ID: 29580042
[TBL] [Abstract][Full Text] [Related]
39. Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women.
Wu H; Shang X; Shi Y; Yang Z; Zhao J; Yang M; Li Y; Xu S
Oncotarget; 2016 Jul; 7(27):41047-41052. PubMed ID: 27166268
[TBL] [Abstract][Full Text] [Related]
40. HIPEC ROC I: a phase I study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer.
Zivanovic O; Abramian A; Kullmann M; Fuhrmann C; Coch C; Hoeller T; Ruehs H; Keyver-Paik MD; Rudlowski C; Weber S; Kiefer N; Poelcher ML; Thiesler T; Rostamzadeh B; Mallmann M; Schaefer N; Permantier M; Latten S; Kalff J; Thomale J; Jaehde U; Kuhn WC
Int J Cancer; 2015 Feb; 136(3):699-708. PubMed ID: 24895230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
